Bleomycin This page contains brief information about bleomycin and a collection of links about the use of this drug, related news and research results, and ongoing clinical trials. US Brand Name(s): | | Blenoxane | | | FDA Approved: | | Yes |
Bleomycin is approved by the Food and Drug Administration (FDA) to treat malignant pleural effusion and keep it from recurring (coming back). Bleomycin is also approved to be used alone or with other drugs as palliative treatment for the following types of cancer:
In addition to the uses that have been approved by the FDA, bleomycin is sometimes used alone or with other drugs to treat other types of cancer. The drug also continues to be studied in the treatment of many types of cancer. Information from the NCIDefinition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trial Results: Positron Emission Tomography (PET) Can Strongly Predict Likelihood of Early Relapse in Hodgkin Lymphoma (08/10/2007) - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Lower-Toxicity Treatment Effective in Some Cases of Early-Stage Hodgkin Lymphoma (07/10/2006) - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Endorses Chemotherapy Alone for Early-Stage Lymphoma (03/29/2005) - Information about the use of this drug to treat cancer.
Breast Cancer Risk Among Young Women with Hodgkin Disease (07/22/2003) - Information from the NCI Press Office about this drug.
Information from the National Library of Medicine (NLM)
MedlinePlus Information on Bleomycin - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied. Clinical TrialsClinical Trials for Bleomycin Sulfate - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.
Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
Back to Top |